Researchers have identified a groundbreaking link between the CHCHD2 gene and Huntington’s disease (HD), a genetic neurodegenerative disorder. For the first time, this gene has been implicated ...
On Wednesday, BofA Securities revised its price target for Huntington Ingalls Industries (NYSE:HII), a major shipbuilding company, reducing it from $250 to $195. The firm maintained its Underperform ...
Citi raised the firm’s price target on Huntington Bancshares (HBAN) to $21 from $18 and keeps a Buy rating on the shares. The firm says Huntington continues to be one of its favored names among ...
On Monday, Evercore ISI maintained a positive outlook on Huntington Bancshares Incorporated (NASDAQ: NASDAQ:HBAN), raising the price target from $18.00 to $20.00 while reaffirming an Outperform rating ...